Episode
Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit
- Podcast
- Breast Cancer Update
- Published
- Jun 20, 2026
- Duration seconds
- 2959
- Processing state
not_requested- Canonical source
- https://breast-oncology.captivate.fm/episode/6009-gmo26-tnbc
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Adam M Brufsky and Dr Kevin Kalinsky, including the following topics: Introduction (0:00) Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Therapy for Triple-Negative Breast Cancer (TNBC) — Dr Brufsky (5:08) Established Treatment Paradigm for Localized and Metastatic TNBC — Dr Kalinsky (35:20) CME information and select publications